inPROBE
@inPROBE_
Disruptive Cancer Diagnostics Platform Technology. SME Instrument Horizon2020 Co-funded. NCBiR Polish Research Programme Co-funded. Lifesaving Innovations
ID:955442792871923712
http://www.inprobe.com 22-01-2018 14:11:27
444 Tweets
181 Followers
672 Following
Great to be on the main page of the European Investment Bank
Small thing but so important to everyone involved ๐
โฌ10mln venture debt funding well secured !!! ๐ช
SDS Optic inPROBE European Commission European Innovation Council EISMEA Lublin
โก๏ธWe start technological cooperation with #Philips Engineering Solutions and the CSEM research and development institute from Switzerland.
โก๏ธ Plan: to scale up, from the level of a clinical #prototype to the level of a #commercial / industrial device, the #inPROBE analyzer.
Busy Friday in #Philadelphia reviewing different lab spaces with all SDS Optic #CoFounders
#SDSOpticUSA moving ahead ๐ช
Great places, great people and great #Philly #Biotech #LifeSciences ecosystem
inPROBE Pennsylvania City of Philadelphia
I Am Biotech International Convention Day 2
Another day of tremendous talks, opportunities and ideas.
We are more than happy to meet our friends from PAIH Central European BioForum BioInMed booth as well as the biosaxony , #Pennsylvania State and European Innovation Council
#networking #bio2023
Real-time cancer diagnosis with a molecular test at the tip of a probe | SDS-OmiProbe Project | Results in brief | H2020 | CORDIS | European Commission โฆEU Research Resultsโฉ โฆEuropean Innovation Councilโฉ โฆSDS Opticโฉ โฆinPROBEโฉ โฆEuropean Commissionโฉ โฆ cordis.europa.eu/article/id/443โฆ
๐ฌ๐ง EU Research Results ๐ช๐บ about SDS Optic and inPROBE
๐ ๐ฏ๐ฟ๐ฒ๐ฎ๐ธ๐๐ต๐ฟ๐ผ๐๐ด๐ต ๐ฑ๐ถ๐ฎ๐ด๐ป๐ผ๐๐๐ถ๐ฐ ๐ฑ๐ฒ๐๐ถ๐ฐ๐ฒ ๐ผ๐ณ๐ณ๐ฒ๐ฟ๐ ๐ณ๐ฎ๐๐ ๐ฑ๐ถ๐ฎ๐ด๐ป๐ผ๐๐ถ๐ ๐ผ๐ณ ๐ฏ๐ฟ๐ฒ๐ฎ๐๐ ๐ฐ๐ฎ๐ป๐ฐ๐ฒ๐ฟ ๐๐ถ๐๐ต๐ผ๐๐ ๐ฎ ๐ป๐ฒ๐ฒ๐ฑ ๐ณ๐ผ๐ฟ ๐ฏ๐ถ๐ผ๐ฝ๐๐
More in the article ๐ cordis.europa.eu/article/id/443โฆ
Very important update by ASCO & CAPathologists
Clear need for novel and potentially disruptive innovations in the #HER2 #molecular #diagnostics #immunoassay space.
SDS Optic EIT Health European Innovation Council NIH Society for Immunotherapy of Cancer SABCS ESMO - Eur. Oncology European Research Executive Agency FDA Oncology OncoAlert
๐USPSTF recommendation
'All women should get screened for breast cancer every other year starting at age 40 to reduce the risk of dying'
โก๏ธAfter mammography (early stage), another important step: developing effective companion diagnostics, like #inPROBE
uspreventiveservicestaskforce.org/uspstf/draft-rโฆ
๐ฅ We received a report confirming the completion of the safety phase of #ClinicalTrials of the #inPROBE , a #MedicalDevice designed to breast cancer real-time #diagnostics .
๐inPROBE: inprobe.com
๐SDS Optic: sdsoptic.pl/en/main-en/
#sdsoptic #innovation #medtech
#GLOBOCAN data shows, that now we have over 2 mln new cases of #breastcancer globally, where almost 700k ends with deaths.
Today is the #WorldCancerDay . Remember about regular breast cancer screenings.
#BreastCancerAwareness #EarlyDetectionMatters #PinkRibon
๐ฌ๐ง ๐ In the
European Investment Bank data base official information has appeared about assessing of the potential financing in the venture debt loan up to EUR 10 mln. for SDS Optic company. ๐ค
๐ฅ๐ฌ๐ง MEDICA 2022 is coming and SDS Optic will be there. You will find us in ๐๐ฎ๐น๐น ๐ญ๐ฎ, ๐๐๐ฎ๐ป๐ฑ ๐ญ๐ฎ๐๐ฑ๐ฏ-๐ฐ๐ฏ.
Don't miss out our ๐ฐ๐ผ๐บ๐ฝ๐ฎ๐ป๐ ๐ฝ๐ฟ๐ฒ๐๐ฒ๐ป๐๐ฎ๐๐ถ๐ผ๐ป ๐ฎ๐ ๐๐ต๐ฒ ๐๐๐ฎ๐ด๐ฒ (Hall 12, Stand 12E37), on Thursday (17'th of November) at 13:20!